View in EDS HTML Full Text PDF Full Text

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.

Saved in:
Bibliographic Details
Title: Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Authors: Kircik LH; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana Medical Center, Indianapolis, IN, USA.; Physicians Skin Care PLLC, Louisville, KY, USA.; Skin Sciences PLLC, Louisville, KY, USA., Alonso-Llamazares J; Driven Research LLC, Coral Gables, FL, USA., Bhatia N; Therapeutics Clinical Research, San Diego, CA, USA., Bukhalo M; Arlington Dermatology, Rolling Meadows, IL, USA., Devani AR; Dermatology Research Institute, Calgary, AB, Canada.; Skin Health and Wellness Centre, Calgary, AB, Canada.; Probity Medical Research, Calgary, AB, Canada., Draelos ZD; Dermatology Consulting Services, High Point, NC, USA., DuBois J; DermResearch Inc., Austin, TX, USA., Gooderham MJ; SkiN Centre for Dermatology, Peterborough, ON, Canada.; Probity Medical Research, Peterborough, ON, Canada.; Queen's University, Peterborough, ON, Canada., Kempers SE; Minnesota Clinical Study Center, Fridley, MN, USA., Lain E; Sanova Dermatology, Austin, TX, USA., Lee M; Progressive Clinical Research, San Antonio, TX, USA., Moore A; Arlington Research Center, Arlington, TX, USA.; Baylor University Medical Center, Dallas, TX, USA., Murrell DF; Faculty of Medicine, University of NSW, Sydney, Australia., Papp KA; Probity Medical Research, Waterloo, ON, Canada.; K. Papp Clinical Research, Waterloo, ON, Canada., Pariser DM; Eastern Virginia Medical School, Norfolk, VA, USA.; Virginia Clinical Research Inc., Norfolk, VA, USA., Sinclair R; Sinclair Dermatology, East Melbourne, Australia., Zirwas M; Dermatologists of the Central States, Probity Medical Research, Bexley, OH, USA.; Ohio University, Bexley, OH, USA., Burnett P; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA., Higham RC; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA., Krupa D; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA., Berk DR; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA.
Source: The British journal of dermatology [Br J Dermatol] 2023 Sep 15; Vol. 189 (4), pp. 392-399.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37279795
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kircik+LH%22">Kircik LH</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana Medical Center, Indianapolis, IN, USA.; Physicians Skin Care PLLC, Louisville, KY, USA.; Skin Sciences PLLC, Louisville, KY, USA.<br /><searchLink fieldCode="AU" term="%22Alonso-Llamazares+J%22">Alonso-Llamazares J</searchLink>; Driven Research LLC, Coral Gables, FL, USA.<br /><searchLink fieldCode="AU" term="%22Bhatia+N%22">Bhatia N</searchLink>; Therapeutics Clinical Research, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bukhalo+M%22">Bukhalo M</searchLink>; Arlington Dermatology, Rolling Meadows, IL, USA.<br /><searchLink fieldCode="AU" term="%22Devani+AR%22">Devani AR</searchLink>; Dermatology Research Institute, Calgary, AB, Canada.; Skin Health and Wellness Centre, Calgary, AB, Canada.; Probity Medical Research, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Draelos+ZD%22">Draelos ZD</searchLink>; Dermatology Consulting Services, High Point, NC, USA.<br /><searchLink fieldCode="AU" term="%22DuBois+J%22">DuBois J</searchLink>; DermResearch Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gooderham+MJ%22">Gooderham MJ</searchLink>; SkiN Centre for Dermatology, Peterborough, ON, Canada.; Probity Medical Research, Peterborough, ON, Canada.; Queen's University, Peterborough, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Kempers+SE%22">Kempers SE</searchLink>; Minnesota Clinical Study Center, Fridley, MN, USA.<br /><searchLink fieldCode="AU" term="%22Lain+E%22">Lain E</searchLink>; Sanova Dermatology, Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lee+M%22">Lee M</searchLink>; Progressive Clinical Research, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Moore+A%22">Moore A</searchLink>; Arlington Research Center, Arlington, TX, USA.; Baylor University Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Murrell+DF%22">Murrell DF</searchLink>; Faculty of Medicine, University of NSW, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Papp+KA%22">Papp KA</searchLink>; Probity Medical Research, Waterloo, ON, Canada.; K. Papp Clinical Research, Waterloo, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Pariser+DM%22">Pariser DM</searchLink>; Eastern Virginia Medical School, Norfolk, VA, USA.; Virginia Clinical Research Inc., Norfolk, VA, USA.<br /><searchLink fieldCode="AU" term="%22Sinclair+R%22">Sinclair R</searchLink>; Sinclair Dermatology, East Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Zirwas+M%22">Zirwas M</searchLink>; Dermatologists of the Central States, Probity Medical Research, Bexley, OH, USA.; Ohio University, Bexley, OH, USA.<br /><searchLink fieldCode="AU" term="%22Burnett+P%22">Burnett P</searchLink>; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA.<br /><searchLink fieldCode="AU" term="%22Higham+RC%22">Higham RC</searchLink>; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA.<br /><searchLink fieldCode="AU" term="%22Krupa+D%22">Krupa D</searchLink>; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berk+DR%22">Berk DR</searchLink>; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220004041%22">The British journal of dermatology</searchLink> [Br J Dermatol] 2023 Sep 15; Vol. 189 (4), pp. 392-399.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0004041 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2133 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070963%22">00070963 </searchLink><i>NLM ISO Abbreviation: </i>Br J Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37279795
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/bjd/ljad182
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 392
    Titles:
      – TitleFull: Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kircik LH
      – PersonEntity:
          Name:
            NameFull: Alonso-Llamazares J
      – PersonEntity:
          Name:
            NameFull: Bhatia N
      – PersonEntity:
          Name:
            NameFull: Bukhalo M
      – PersonEntity:
          Name:
            NameFull: Devani AR
      – PersonEntity:
          Name:
            NameFull: Draelos ZD
      – PersonEntity:
          Name:
            NameFull: DuBois J
      – PersonEntity:
          Name:
            NameFull: Gooderham MJ
      – PersonEntity:
          Name:
            NameFull: Kempers SE
      – PersonEntity:
          Name:
            NameFull: Lain E
      – PersonEntity:
          Name:
            NameFull: Lee M
      – PersonEntity:
          Name:
            NameFull: Moore A
      – PersonEntity:
          Name:
            NameFull: Murrell DF
      – PersonEntity:
          Name:
            NameFull: Papp KA
      – PersonEntity:
          Name:
            NameFull: Pariser DM
      – PersonEntity:
          Name:
            NameFull: Sinclair R
      – PersonEntity:
          Name:
            NameFull: Zirwas M
      – PersonEntity:
          Name:
            NameFull: Burnett P
      – PersonEntity:
          Name:
            NameFull: Higham RC
      – PersonEntity:
          Name:
            NameFull: Krupa D
      – PersonEntity:
          Name:
            NameFull: Berk DR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 09
              Text: 2023 Sep 15
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2133
          Numbering:
            – Type: volume
              Value: 189
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: The British journal of dermatology
              Type: main
ResultId 1